The social media buzz on the annual HIV science conference.

Truvada metabolizes differently in the vagina than in the rectum, leaving less room for error in protecting vaginal tissues from HIV.

Not sticking to the daily HIV medication regimen is also associated with increased health care costs.

People treated with VRC01 maintained undetectable viral load for up to 42 weeks after stopping antiretroviral therapy.

A survey of transgender women found such concerns led many to take their hormones or HIV meds not as prescribed.

Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.

Highly precise analyses of diagnosis and treatment statistics in hard-hit Zambia, Zimbabwe and Malawi reveal crucial disparities.

PrEP use remains largely limited to white men 25 and older, meaning groups at the very highest risk of HIV are likely not benefiting.

A recent analysis helped shed light on the stillborn rate among those living in wealthier nations.

Such generic drugs could save nations huge sums in the coming years.